Regeneron NASDAQ: REGN www.regeneron.com
Tarrytown, US · 4 known investors
Regeneron discovers, develops, and manufactures biologics and genetic medicines for treating serious diseases including metabolic disorders, ophthalmology conditions, and rare diseases. The company serves patients globally through clinical trials and commercial pharmaceutical products.
BiotechHealthtechMedical Devices